Supplemental methods ("Guselkumab and risankizumab for psoriasis: a 44-week indirect real life comparison ")

Published: 12 January 2021| Version 1 | DOI: 10.17632/9by92fmdsx.1
Contributors:
Angelo Ruggiero,
Gabriella Fabrocini,
Eleonora Cinelli,
Matteo Megna

Description

Supplemental methods

Files